Skip to main content
Top
Published in: Clinical and Translational Allergy 1/2019

Open Access 01-12-2019 | Omalizumab | Letter to the Editor

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema

Authors: Zonne L. M. Hofman, Nikki van West, C. Erik Hack, André C. Knulst, Coen Maas, Heike Röckmann

Published in: Clinical and Translational Allergy | Issue 1/2019

Login to get access

Abstract

Antihistamines are the most prescribed therapy in recurrent idiopathic angioedema, yet little is known about their efficacy. Herein, we report on clinical improvement with antihistamine therapy in 120 patients evaluating angioedema attack frequency. A high incidence (36%) of antihistamine refractory cases was observed. Forty percent of patients on antihistamine prophylaxis suffered from 1 or more angioedema attacks per month. Our findings stress the need for additional treatment options for recurrent idiopathic angioedema.
Literature
2.
go back to reference Bork K, Barnstedt S-E. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc. 2003;134(8):1088–94.CrossRef Bork K, Barnstedt S-E. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc. 2003;134(8):1088–94.CrossRef
5.
Metadata
Title
High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema
Authors
Zonne L. M. Hofman
Nikki van West
C. Erik Hack
André C. Knulst
Coen Maas
Heike Röckmann
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2019
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/s13601-019-0274-7

Other articles of this Issue 1/2019

Clinical and Translational Allergy 1/2019 Go to the issue